MX377022B - Composiciones de lágrimas artificiales. - Google Patents

Composiciones de lágrimas artificiales.

Info

Publication number
MX377022B
MX377022B MX2015018028A MX2015018028A MX377022B MX 377022 B MX377022 B MX 377022B MX 2015018028 A MX2015018028 A MX 2015018028A MX 2015018028 A MX2015018028 A MX 2015018028A MX 377022 B MX377022 B MX 377022B
Authority
MX
Mexico
Prior art keywords
artificial tear
tear compositions
compositions
artificial
ionic surfactants
Prior art date
Application number
MX2015018028A
Other languages
English (en)
Other versions
MX2015018028A (es
Inventor
Gerald Horn
Original Assignee
Ps Therapies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/924,214 external-priority patent/US8597629B1/en
Application filed by Ps Therapies Ltd filed Critical Ps Therapies Ltd
Publication of MX2015018028A publication Critical patent/MX2015018028A/es
Publication of MX377022B publication Critical patent/MX377022B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención proporciona composiciones de lágrimas artificiales que comprenden uno o más agentes tensoactivos no iónicos con uno o más excipientes mejoradores de la viscosidad no newtonianos.
MX2015018028A 2013-06-21 2014-06-13 Composiciones de lágrimas artificiales. MX377022B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/924,214 US8597629B1 (en) 2013-06-21 2013-06-21 Artificial tear compositions comprising a combination of nonionic surfactants
US14/034,667 US20140377210A1 (en) 2013-06-21 2013-09-24 Artificial tear compositions
PCT/US2014/042220 WO2014204790A1 (en) 2013-06-21 2014-06-13 Artifical tear compositions

Publications (2)

Publication Number Publication Date
MX2015018028A MX2015018028A (es) 2016-08-05
MX377022B true MX377022B (es) 2025-03-07

Family

ID=52105137

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015018028A MX377022B (es) 2013-06-21 2014-06-13 Composiciones de lágrimas artificiales.
MX2020004782A MX2020004782A (es) 2013-06-21 2015-12-21 Composiciones de lagrimas artificiales.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2020004782A MX2020004782A (es) 2013-06-21 2015-12-21 Composiciones de lagrimas artificiales.

Country Status (5)

Country Link
US (1) US20140377210A1 (es)
CN (1) CN105555137A (es)
BR (1) BR112015032110A2 (es)
MX (2) MX377022B (es)
WO (1) WO2014204790A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9675537B2 (en) 2014-06-30 2017-06-13 Johnson & Johnson Consumer Inc. Hair growth composition and method
US11260035B2 (en) 2016-10-12 2022-03-01 Ps Therapies Ltd Topical compositions and methods of use thereof
US20200009044A1 (en) * 2016-10-12 2020-01-09 Ps Therapies Ltd Artificial tear, contact lens and drug vehicle compositions and methods of use thereof
US11583496B2 (en) 2016-10-12 2023-02-21 PS Therapy Inc. Drug vehicle compositions and methods of use thereof
JP7073358B2 (ja) * 2016-10-12 2022-05-23 ピー・エス・セラピー・リミテッド 人工涙液、コンタクトレンズ及び薬剤担体組成物並びにその使用方法
US11026884B2 (en) * 2018-01-24 2021-06-08 Eye Therapies Llc Methods for improving vision
CN113227304A (zh) * 2018-09-21 2021-08-06 Ps治疗有限公司 人工泪液、隐形眼镜和药物载体组合物及其使用方法
CN121129888A (zh) * 2025-11-19 2025-12-16 山东第一医科大学附属眼科医院(山东省眼科医院) 一种长效温敏型术中眼表保护剂及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
EP1050304A1 (en) * 1998-11-16 2000-11-08 Rohto Pharmaceutical Co., Ltd. Liquid ophthalmic preparations
WO2005025539A1 (ja) * 2003-09-10 2005-03-24 Senju Pharmaceutical Co., Ltd. コンタクトレンズ用眼科用組成物
US9161905B2 (en) * 2005-01-12 2015-10-20 Ocular Research Of Boston, Inc. Dry eye treatment
WO2010059894A1 (en) * 2008-11-21 2010-05-27 Bridge Pharma, Inc. Ocular formulations of norketotifen
MX2012006401A (es) * 2009-12-03 2012-07-10 Lupin Ltd Proceso para preparar composiciones oftalmicas farmaceuticas.
US8957048B2 (en) * 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
US8597629B1 (en) * 2013-06-21 2013-12-03 Premium Ocular Solutions LLC. Artificial tear compositions comprising a combination of nonionic surfactants

Also Published As

Publication number Publication date
WO2014204790A1 (en) 2014-12-24
BR112015032110A2 (pt) 2017-11-21
CN105555137A (zh) 2016-05-04
US20140377210A1 (en) 2014-12-25
MX2020004782A (es) 2020-08-13
MX2015018028A (es) 2016-08-05

Similar Documents

Publication Publication Date Title
DK3687994T3 (da) Gadolinium-bærende pcta-baserede kontrastmidler
MX377022B (es) Composiciones de lágrimas artificiales.
CL2016002772A1 (es) Composiciones de insulina de rápida acción
CO2017008219A2 (es) Composición hemostática y dispositivo hemostático (variantes)
BR112017005381A2 (pt) composições que compreendem células recombinantes de bacillus e um inseticida.
BR112017018276A2 (pt) ?composição que compreende peptidase e biotensoativo e seu uso?
DK3601553T3 (da) Alfa-amylase-kombinationsvarianter
CY1123622T1 (el) Τροποποιημενα μηνιγγιτιδοκοκκικα fhbp πολυπεπτιδια
BR112017004573A2 (pt) composições detergentes contendo um tensoativo ramificado
BR112017009374A2 (pt) ?composições de ramnolipídeo de baixa viscosidade concentradas?
MX2017010872A (es) Composiciones que comprenden combinaciones de cannabinoides purificados, con al menos uno de flavonoides, terpenos o minerales.
BR112017005507A2 (pt) composições que compreendem células recombinantes de bacillus e um fungicida.
CY1124425T1 (el) Συνθεσεις οι οποιες περιλαμβανουν συζευγματα φαρμακου αντισωματος-δουοκαρμυκινης
EA201690613A1 (ru) Улучшенные составы на основе аденовирусов
EA201790380A1 (ru) Ингибиторы mk2 и их применения
BR112017005504A2 (pt) composições que compreendem células recombinantes de bacillus e um inseticida.
BR112017005379A2 (pt) composições que compreendem células recombinantes de bacillus e um fungicida.
EP3601569A4 (en) PCSK9 EXPRESSION MODULATORS
EP3702434C0 (en) LUBRICATING COMPOSITION
EP3762021A4 (en) ATTACHED FLAVIRUSES
EP3849433C0 (en) Wedge-Driven Suture Anchor
JO3456B1 (ar) فيروتيوكسيتين بيروجلوتامات
EP3578624A4 (en) LUBRICANT COMPOSITION
ES1216222Y (es) Composicion que comprende cenizas de cremacion
EP3693771A4 (en) OPTOISOLATOR

Legal Events

Date Code Title Description
FG Grant or registration